• Author: Brandon Nokes
Clear all

Impact of medical comorbidities on ketamine and esketamine treatment effectiveness for posttraumatic stress disorder and depression: A clinical outcomes analysis from the VA San Diego Healthcare System

Abstract: BACKGROUND: Ketamine and esketamine are increasingly used to manage treatment-resistant depression and have also been shown to reduce symptoms of posttraumatic stress …

The effect of obstructive sleep apnea severity on PTSD symptoms during the course of esketamine treatment: A retrospective clinical study

Abstract: STUDY OBJECTIVES: Intranasal administration of esketamine is Food and Drug Administration-approved for treatment-resistant depression. In a recent retrospective case …